29 July 2026
Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.
28 July 2026
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
27 July 2026
Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
27 July 2026
The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family's representation.
24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
23 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
23 July 2026
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.
22 July 2026
PEPFAR cuts have been linked to a 45% decline in South African children receiving HIV treatment at US-supported healthcare sites.
22 July 2026
Fake medical certificates are driving sick leave abuse in South Africa, costing employers through absenteeism, fraud and lost productivity.
21 July 2026
Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.
21 July 2026
The Extensior South Africa launch on 27 July, offering patients a lower-cost, authorised semaglutide treatment for type 2 diabetes.
20 July 2026
Ambulance tariff negotiations could help private emergency service providers address low payments, cash-flow pressure and market contraction.